Patent ID: 7229592
Filing Date: 2007-06-12
Classification: G01N,Y10T

Abstract:
1. An analytical analyzer adapted for automatically conducting clinical assays on patient samples in reaction cuvettes, said analyzer comprising: a rotating reaction carousel supporting a cuvette carousel having cuvette ports adapted to receive a plurality of reaction cuvettes; cuvette load and unload stations positioned proximate the cuvette carousel and adapted to load unused, new cuvettes into cuvette ports and remove cuvettes from cuvette ports; a cuvette wash station accessible by said cuvette load and unload stations and adapted to wash used cuvettes, thereby providing cleaned used reaction cuvettes; a new cuvette store accessible by said cuvette load stations and containing unused, new cuvettes; and, analyzer control means for determining if the assay scheduled to be next performed is an assay for triglycerides and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of urea, uric acid, creatine kinase-mb, amylase, ammonia or lactic acid, then requiring an unused reaction cuvette be used; or, determining if the assay scheduled to be next performed is an assay for magnesium and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of alkaline phosphatase or creatine kinase, then requiring an unused reaction cuvette be used; or, if the assay scheduled to be next performed is an assay for phosphorus and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of pseudocholinesterase, theophylline, c-reactive protein, or phenytoin, then requiring an unused reaction cuvette be used; or, if the assay scheduled to be next performed is an assay for ammonia or pretein-urine csf and the assay previously performed in said cleaned used reaction cuvette was an assay for at least ethyl alcohol, then requiring an unused reaction cuvette be used; or, if the assay scheduled to be next performed is an assay for total bilirubin and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of pretein-urine csf or total protein, then requiring an unused reaction cuvette be used; or, if the assay scheduled to be next performed is an assay for lactate dehydrogenase and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of lactic acid csf, aspartate aminotransferase or alanine aminotransferase, then requiring an unused reaction cuvette be used; or, if the assay scheduled to be next performed is an assay for urine amphetamine, urine barbituate, urine benzodiazephen, urine cocaine or urine methamphetamine and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of carbamazepine, then requiring an unused reaction cuvette be used; or, if the assay scheduled to be next performed is an assay for triglycerides and the assay previously performed in said cleaned used reaction cuvette was an assay for at least one of alkaline phosphatase, creatine kinase, or pseudocholinesterase, then requiring an unused reaction cuvette be used.